描述

Short-chain fatty acid concentrations measured in IBS-D participants after Lactiplantibacillus plantarum GTB1 or placebo administration. Alterations in SCFA levels are associated with changes in gut fermentation patterns during the intervention period.

Figure 10

Chart

Source Paper

Effect of Oral Intake of Lactiplantibacillus plantarum APsulloc 331261 (GTB1TM) on Diarrhea-Predominant Irritable Bowel Syndrome: A Randomized, Double-Blind, Placebo-Controlled Study.

Nutrients (2022)

PMID: 35631156

DOI: 10.3390/nu14102015

Cite This Figure

![Figure 10: Short-chain fatty acid concentrations measured in IBS-D participants after Lactiplantibacillus plantarum GTB1 or placebo administration. Alterations in SCFA levels are associated with changes in gut fermentation patterns during the intervention period.]()

> Source: Kyoungmi Jung et al. "Effect of Oral Intake of Lactiplantibacillus plantarum APsulloc 331261 (GTB1TM) ." *Nutrients*, 2022. PMID: [35631156](https://pubmed.ncbi.nlm.nih.gov/35631156/)

<figure>
  <img src="" alt="Short-chain fatty acid concentrations measured in IBS-D participants after Lactiplantibacillus plantarum GTB1 or placebo administration. Alterations in SCFA levels are associated with changes in gut fermentation patterns during the intervention period." />
  <figcaption>Figure 10. Short-chain fatty acid concentrations measured in IBS-D participants after Lactiplantibacillus plantarum GTB1 or placebo administration. Alterations in SCFA levels are associated with changes in gut fermentation patterns during the intervention period.<br>  Source: Kyoungmi Jung et al. "Effect of Oral Intake of Lactiplantibacillus plantarum APsulloc 331261 (GTB1TM) ." <em>Nutrients</em>, 2022. PMID: <a href="https://pubmed.ncbi.nlm.nih.gov/35631156/">35631156</a></figcaption>
</figure>

描述

Figure 10

Source Paper

Cite This Figure

相关证据